US
US Stress Relief Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $1.59 Bn.
Canada at 8.3% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.19 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.50 Bn | — | — |
| 2025 (base) | $1.59 Bn | +$95.9 Mn | — |
| 2026 (forecast) | $1.70 Bn | +$102.0 Mn | +6.4% |
| 2027 (forecast) | $1.80 Bn | +$108.5 Mn | +13.2% |
| 2028 (forecast) | $1.92 Bn | +$115.5 Mn | +20.5% |
| 2029 (forecast) | $2.04 Bn | +$122.8 Mn | +28.2% |
| 2030 (forecast) | $2.17 Bn | +$130.7 Mn | +36.4% |
| 2031 (forecast) | $2.31 Bn | +$139.1 Mn | +45.1% |
| 2032 (forecast) | $2.46 Bn | +$148.0 Mn | +54.4% |
| 2033 (forecast) | $2.62 Bn | +$157.4 Mn | +64.3% |
| 2034 (forecast) | $2.79 Bn | +$167.5 Mn | +74.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$1.59 Bn
China
$305.0 Mn
Canada
$290.5 Mn
Japan
$286.1 Mn
Germany
$143.8 Mn
France
$125.6 Mn
Brazil
$111.6 Mn
Italy
$93.6 Mn
UK
$91.1 Mn
Ecuador
$86.2 Mn
Spain
$81.2 Mn
Saudi Arabia
$80.9 Mn
India
$81.5 Mn
Mexico
$68.0 Mn
Australia
$46.5 Mn
New Zealand
$44.2 Mn
Russia
$43.6 Mn
South Africa
$28.9 Mn
UAE
$19.4 Mn
Egypt
$12.0 Mn
Philippines
$9.5 Mn
Hong Kong
$7.1 Mn
Malaysia
$6.4 Mn
Singapore
$4.5 Mn
Thailand
$4.4 Mn
Kenya
$3.2 Mn
Stress relief supplements contain ingredients such as ashwagandha, magnesium, L-theanine and herbal blends marketed to ease stress and support calm.
Key segments of the stress Relief Supplements market include ingredient (Ashwagandha, Magnesium and L-Theanine) and form (Capsules, Gummies and Powders).
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the stress Relief Supplements market. Governments and employers are investing more in mental health care.
Digital tools, new drug classes and care built into primary care and workplaces give the stress Relief Supplements market strong room to grow worldwide.
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the stress Relief Supplements market.
The stress Relief Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Food and supplement rules, labelling and health-claim regulations govern stress Relief Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in US.
What doctors and scientists are doing in Stress Relief Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
US · 5 shared keywords
US · 5 shared keywords
US · 4 shared keywords
US · 4 shared keywords
US · 4 shared keywords
US · 4 shared keywords
Pharmaceuticals · US
Digital Health · US
Digital Health · US
Pharmaceuticals · US
Pharmaceuticals · US
Healthcare Services · US